Sign Up for Our Newsletter
Contact Donate

Secondary Hyperparathyroidism

Program Status


Open – We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.

Maximum Award Level

 $4,000 per year

Eligibility Criteria

 Patient must have Medicare insurance and Medicare must cover the medication for which patient seeks assistance.
 Patient has an authenticated Secondary Hyperparathyroidism diagnosis.
 Patient is receiving dialysis treatment for treatment of Chronic Kidney Disease; and 
Patient’s income must fall below 400% of the Federal Poverty Level.

Get Help With Your Treatment

Apply Online (Click Here) or call 1-866-316-PANF (7263)

Billing Instructions for SHPT Providers:

Patients will receive a pharmacy benefits card that lists the ID number, Rx Group number and Rx BIN number; however you don't have to wait for the pharmacy card if you already have the patient approval letter which indicates the ID number (PF number).  Pharmacies with the capability to bill secondary or tertiary claims electronically can submit claims directly to the PAN Foundation using the below information:

Group number: 99990654
BIN number: 006012 
PCN for Medicare D Patients: MEDDPDM 

Information About the Disease

Secondary hyperparathyroidism (SHPT) is when the parathyroid glands in your neck produce too much parathyroid hormone (PTH) because your calcium levels are too low. When calcium levels are too low, the body responds by increasing production of parathyroid hormone. This increase in parathyroid hormone causes more calcium to be taken from the bone and more calcium to be reabsorbed by the intestines and kidney. Kidney failure is a common cause of secondary hyperparathyroidism.

For more information visit the American Thyroid Association website.